Charnwood Campus has recommissioned its world-class synthetic and chemistry research facility to the highest standard to cater to the needs of its newest occupier and leading pre-clinical discovery contract research organisation (CRO) Charnwood Molecular, in a £54m construction project.   The three-storey, state-of-the-art synthetic and chemistry research facility has been fully modernised by engineering firm … Read more

Leading UK pre-clinical discovery CRO servicing the global pharmaceutical and biotechnology market, Charnwood Molecular, has joined Charnwood Campus and expanded its operations in a deal expected to support the growth of its contract research services.   Charnwood Molecular continues to build upon its foundation in medicinal chemistry, scale-up chemistry and custom synthesis provision, evolving its … Read more

Global contract development and manufacturing organisation (CDMO) Kindeva Drug Delivery has expanded its operations at Charnwood Campus, in a deal expected to support Kindeva’s continued growth in the UK.   The US-headquartered company will take over a state-of-the-art research and development facility at Charnwood Campus, and a further 20,000 square feet of office space at the … Read more